1719 Epizód

  1. Hospitalizations in Symptomatic Patients with Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights from RESHAPE-HF2

    Közzétéve: 2024. 12. 02.

  2. Artificial Intelligence-Enhanced Electrocardiogram Diastolic Function Assessment for Prognostic Stratification in Mitral Regurgitation

    Közzétéve: 2024. 11. 25.

  3. Sudden Death in Obesity: Mechanisms and Management

    Közzétéve: 2024. 11. 25.

  4. Two-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study

    Közzétéve: 2024. 11. 25.

  5. Hypertensive disorders of pregnancy increase risk for myocardial infarction: a population-based study

    Közzétéve: 2024. 11. 25.

  6. JACC - December 3, 2024 Issue Summary

    Közzétéve: 2024. 11. 25.

  7. Length of Hospital Stay for Endocarditis. Before and After Partial Oral Treatment of Endocarditis Trial

    Közzétéve: 2024. 11. 25.

  8. Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of Four Trials

    Közzétéve: 2024. 11. 21.

  9. JACC - SUMMIT 2024: A Video Interview with Harlan Krumholz and Milton Packer| JACC | AHA 2024

    Közzétéve: 2024. 11. 20.

  10. JACC - Recap of AHA From Harlan Krumholz, Editor-in-Chief

    Közzétéve: 2024. 11. 20.

  11. JACC - Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients with Heart Failure

    Közzétéve: 2024. 11. 20.

  12. JACC - Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity

    Közzétéve: 2024. 11. 20.

  13. JACC - Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy

    Közzétéve: 2024. 11. 20.

  14. JACC - Outpatient Worsening Heart Failure in Patients with ATTR CM in the HELIOS-B Trial | JACC | AHA 2024

    Közzétéve: 2024. 11. 20.

  15. JACC - Five-Year Results from the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial

    Közzétéve: 2024. 11. 20.

  16. JACC - Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study

    Közzétéve: 2024. 11. 20.

  17. JACC - DanGer Shock trial: The impact of age | JACC | AHA 2024

    Közzétéve: 2024. 11. 20.

  18. JACC - Oxidized Phospholipids and Calcific Aortic Valvular Disease

    Közzétéve: 2024. 11. 20.

  19. JACC - Accelerometer-Measured Sedentary Behavior & Risk of Future Cardiovascular Disease | JACC | AHA 2024

    Közzétéve: 2024. 11. 20.

  20. JACC - P2Y12 Inhibitor Pretreatment in Non-ST Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry

    Közzétéve: 2024. 11. 20.

11 / 86

Each week, Valentin Fuster, MD, PhD, MACC, records free podcasts highlighting journal findings. To keep clinicians updated on the most important science emerging in clinical and translational cardiology, Dr. Fuster provides an overview of the weekly edition from the Journal of the American College of Cardiology (JACC), as well as a short summary of each manuscript. Encompassing JACC and nine cardiovascular specialty journals, the JACC family of journals rank among the top cardiovascular peer-reviewed journals in the world for scientific impact.

Visit the podcast's native language site